Trials / Completed
CompletedNCT03848767
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges
An Early Feasibility Study to Evaluate the Functionality and Safety of an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus During Meal Challenges
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The Automated Insulin Delivery (AID) System is an investigational insulin delivery device being developed for use for participants with diabetes. The purpose of this study is to assess the safety of the AID system during meal challenges.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AID System | AID System |
| DRUG | Insulin Lispro | Individualized doses of insulin lispro administered via the AID system to maintain glycemic control except during meal challenges. |
Timeline
- Start date
- 2019-02-20
- Primary completion
- 2019-04-01
- Completion
- 2019-04-01
- First posted
- 2019-02-21
- Last updated
- 2019-04-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03848767. Inclusion in this directory is not an endorsement.